Angiosarcoma of the Scalp and Face: A Dosimetric Comparison of HDR Surface Applicator Brachytherapy and VMAT
Comparing treatment plans for a single patient. (a) The delivered HDR-SA brachytherapy isodose distribution for a scalp angiosarcoma patient. (b) The paired VMAT isodose distribution for the same patient. Magenta line denotes the PTV.
Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.